• Featured Product
  • KD/KO Validated

CoraLite®568-conjugated ATP5A1 Monoclonal antibody

ATP5A1 Monoclonal Antibody for

Host / Isotype

Mouse / IgG2b

Reactivity

human, mouse, rat, monkey

Applications

Conjugate

CoraLite®568 Fluorescent Dye

CloneNo.

1B10H3

Cat no : CL568-66037

Print datasheet

Synonyms

ATP5A 1, ATP5A, ATP synthase F1 subunit alpha, 1B10H3



Planning an IHC experiment? We recommend our IHCeasy ATP5A1 Ready-To-Use IHC Kit. ATP5A1 primary antibody included.
For other applications, we recommend the unconjugated version of this antibody, 66037-1-Ig

产品信息

CL568-66037 targets ATP5A1 in applications and shows reactivity with human, mouse, rat, monkey samples.

Tested Applications Application Description
Tested Reactivity human, mouse, rat, monkey
Immunogen ATP5A1 fusion protein Ag8119 种属同源性预测
Host / Isotype Mouse / IgG2b
Class Monoclonal
Type Antibody
Full Name ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle
Synonyms ATP5A 1, ATP5A, ATP synthase F1 subunit alpha, 1B10H3
Calculated Molecular Weight 60 kDa
GenBank Accession NumberBC064562
Gene Symbol ATP5A1
Gene ID (NCBI) 498
RRIDAB_2919718
Conjugate CoraLite®568 Fluorescent Dye
Excitation/Emission Maxima Wavelengths568 nm / 587 nm
Form Liquid
Purification MethodProtein A purification
UNIPROT IDP25705
Storage Buffer PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
Storage ConditionsStore at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

The ATP5A1 gene encodes the α subunit of mitochondrial ATP synthase which produces ATP from ADP in the presence of a proton gradient across the membrane. The mitochondrial ATP synthase, also known as Complex V or F1F0 ATP synthase, is a multi-subunit enzyme complex consisting of two functional domains, the F1-containing the catalytic core and the Fo- containing the membrane proton channel. F0 domain has 10 subunits: a, b, c, d, e, f, g, OSCP, A6L, and F6. F1 is composed of subunits α, β, γ, δ, ε, and a loosely attached inhibitor protein IF1. Recently defect in ATP5A1 has been linked to the fatal neonatal mitochondrial encephalopathy. ATP5A1 is localized in the mitochondria and anti-ATP5A1 can be used as the loading control for mitochondrial or Complex V proteins. This antibody recognizes the endogenous ATP5A1 protein in lysates from various cell lines and tissues. The predicted MW of ATP5A1 is 60 kDa, while it undergoes the transit peptide cleavage to become a mature form around 50-55 kDa. Several isoforms of ATP5A1 exist due to the alternative splicing.